OTC Group and Xerox Thwart Pharmaceutical Counterfeiting and Theft

In 2013, the United States passed the Drug Quality and Security Act to address counterfeiting and theft, but pharmaceutical companies have struggled to comply with the strict new requirements on the tracking and tracing of drug packaging that the Act mandates.

Existing solutions involve using an inkjet printing process to apply the necessary identifiers at the last stage of packaging. This method has proved insufficient however, and leaves ample opportunity for fraud, especially when package printing and assembly are provided by an outside vendor.